This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28


A look at what's coming to Contemporary OB/GYN® this week.

The effect of eating disorders in pregnancy on neurodevelopmental risk in infants

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Read now

Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma

The latest trial results showed statistically significant improvements in overall survival and progression-free survival.

Read now

Agile Therapeutics partners with Afayxs to expand access to Twirla®

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.

Read now

Check back soon for additional updates.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.